Takeda Pharmaceutical Company Limited (TAK) Earnings Call Analysis
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
14/25
Growth 2
Margin 3
Expansion 4
Platform 1
Financial 4
latest quarter score
Earnings Reports
- 14
- 14
- 17
- 15
- 9